Literature DB >> 21431787

The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.

Hajime Sato1, Jun Tomio, Yoshiaki Tanaka, Emiko Iwasaki.   

Abstract

OBJECTIVES: This study examines the public acceptance of smallpox vaccinations in the event of a terrorist attack using smallpox. The article also provides public health professionals with the information necessary for such smallpox management.
METHODS: A questionnaire survey was conducted in a city in Japan asking about prospective action when smallpox vaccination is advised after a terrorist attack and factors that could influence individual decisions about such vaccination.
RESULTS: Only a tiny fraction of people (0.12%) expressed their rejection of vaccination. Of the respondents, 63.6% showed their intent to be vaccinated promptly when such a measure was required; 28.6% wanted to decide for themselves, having some reservations. Those in the younger age group, those suffering from hypertension/cardiac diseases, and those who considered the threat of smallpox terrorism less seriously were likely to reserve their vaccination decisions until after examining information.
CONCLUSIONS: Communication programs regarding smallpox vaccination should be well planned beforehand and should especially target those people who reserve their decisions at such times. Health professionals should also be well equipped with all information necessary for appropriate and effective smallpox management in the face of such a bioterrorism attack or the strong potential of one.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21431787      PMCID: PMC3156840          DOI: 10.1007/s12199-010-0199-1

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  48 in total

Review 1.  The visual communication of risk.

Authors:  I M Lipkus; J G Hollands
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  [An empirical research for demand of influenza vaccination].

Authors:  M Ii; Y Ohkusa
Journal:  Nihon Koshu Eisei Zasshi       Date:  2001-01

Review 3.  Diagnosis and management of smallpox.

Authors:  Joel G Breman; D A Henderson
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

4.  Public perceptions of information sources concerning bioterrorism before and after anthrax attacks: an analysis of national survey data.

Authors:  William E Pollard
Journal:  J Health Commun       Date:  2003

5.  Strategies to help patients understand risks.

Authors:  John Paling
Journal:  BMJ       Date:  2003-09-27

6.  US smallpox vaccine programme stalls as volunteers balk.

Authors:  Alicia Ault
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

7.  Reasons physicians accepted or declined smallpox vaccine, February through April, 2003.

Authors:  Andrea L Benin; Louise Dembry; Eugene D Shapiro; Eric S Holmboe
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

8.  Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Authors:  Melinda Wharton; Raymond A Strikas; Rafael Harpaz; Lisa D Rotz; Benjamin Schwartz; Christine G Casey; Michele L Pearson; Larry J Anderson
Journal:  MMWR Recomm Rep       Date:  2003-04-04

9.  The public and the smallpox threat.

Authors:  Robert J Blendon; Catherine M DesRoches; John M Benson; Melissa J Herrmann; Kalahn Taylor-Clark; Kathleen J Weldon
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

Review 10.  Smallpox and bioterrorism: public-health responses.

Authors:  Harry F Hull; Richard Danila; Kristen Ehresmann
Journal:  J Lab Clin Med       Date:  2003-10
View more
  1 in total

Review 1.  Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.

Authors:  Hajime Sato
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.